Form 4: Marimed Director Converts RSUs to Common Stock

Marimed Inc. Director Eva M.D. Selhub converted 166,985 Restricted Stock Units into common stock, increasing her direct beneficial ownership to 482,671 shares.

Summary

• Eva M.D. Selhub, a Director of Marimed Inc. (MRMD), acquired 166,985 shares of common stock.
• The acquisition resulted from the conversion of Restricted Stock Units (RSUs) on a one-for-one basis.
• The transaction price for the acquired shares was $0, as it was an RSU conversion.
• Following this transaction, Dr. Selhub beneficially owns 482,671 shares of Marimed Inc. common stock directly.
• The RSUs were granted on December 5, 2025, and vested in full on December 15, 2025.
• These RSUs were granted in lieu of cash payment for a portion of Dr. Selhub's fees for serving on the Issuer's Board of Directors.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive due to increased insider ownership and alignment of director interests with shareholders through equity compensation. It is a routine, expected transaction with no negative surprises.

Positives

• Increased direct beneficial ownership by a director, aligning her interests with shareholders.
• The use of equity (RSUs) for director compensation can incentivize long-term performance and commitment.

Negatives

• Minor dilution to existing shareholders from the issuance of new shares, though this is a standard part of equity compensation plans.

Future Outlook

This filing is a routine disclosure of an insider transaction and does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• The RSUs were granted in lieu of cash as payment for a portion of the Reporting Person's fees for serving on the Issuer's Board of Directors.

Industry Context

Equity compensation, such as Restricted Stock Units (RSUs), is a common practice across various industries, particularly for directors and executives, to align their interests with long-term shareholder value. This transaction reflects a standard method of compensating board members.

Comparison to Industry Standards

• The practice of compensating directors with equity, specifically RSUs, is a widely accepted corporate governance standard among publicly traded companies, including those in the cannabis or related sectors where Marimed Inc. operates.
• This method is often preferred over cash-only compensation as it ties a director's personal financial interest directly to the company's stock performance, similar to practices seen in companies like Canopy Growth (CGC) or Tilray Brands (TLRY) for their board members.
• The conversion of RSUs at a $0 price is typical for such awards, as the value is derived from the underlying common stock at the time of vesting, rather than a purchase price.

Corporate Governance

Related Party Transactions

• The grant of Restricted Stock Units (RSUs) to Eva M.D. Selhub, a Director, for her services on the Board of Directors, constitutes a related party transaction as it involves compensation provided to an insider.

Stakeholder Impact

• Shareholders: The issuance of shares from RSU conversion results in minor dilution but also increases insider ownership, potentially signaling confidence and aligning director interests with shareholder value.
• Employees: No direct impact on employees is indicated by this specific filing.
• Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated by this specific filing.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction involving the conversion of Restricted Stock Units (RSUs) into common stock as part of a director's compensation. While it increases insider ownership, which is generally a positive signal of alignment, it does not provide new material information about the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. It is an expected event within the scope of standard corporate governance and compensation practices.

Keywords

Marimed Inc., MRMD, Eva M.D. Selhub, Director, Insider Transaction, Form 4, Restricted Stock Units, RSU Conversion, Equity Compensation, Beneficial Ownership